Exendin agonist formulations and methods of administration thereof

  • US 6,902,744 B1
  • Filed: 01/14/2000
  • Issued: 06/07/2005
  • Est. Priority Date: 01/14/1999
  • Status: Expired due to Term
First Claim
Patent Images

1. A pharmaceutical formulation which is a liquid dosage form suitable for multi-use administration comprising about 0.005% to about 0.4% (w/v) of exendin-4, a buffer, an iso-osmolality modifier, and about 0.005% to about 1.0% (w/v) of a preservative selected from the group consisting of m-cresol, phenol, alcohol, methyl-, ethyl-, propyl- and butyl-paraben and any combination thereof, wherein said formulation has a pH of between about 3.0 and about 7.0.

View all claims

    Thank you for your feedback